Hainan Shuangcheng Pharmaceuticals Co., Ltd. elected Bai Jing as non-independent director of the company, at its first extraordinary general meeting of 2022 held on 26 January 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.31 CNY | -0.75% | -6.18% | -29.29% |
05-22 | Workshop of Shuangcheng Pharma's Unit Passes Regulatory Inspection; Shares Up 3% | MT |
05-07 | Shuangcheng Pharma Gets FDA Nod to Market Acromegaly Drug in US | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.29% | 305M | |
+16.31% | 42.32B | |
+16.32% | 21.29B | |
+19.44% | 15.29B | |
+18.71% | 14.36B | |
+52.78% | 12.81B | |
-0.05% | 6.79B | |
-12.24% | 6.58B | |
-8.87% | 5.73B | |
+11.64% | 5.51B |
- Stock Market
- Equities
- 002693 Stock
- News Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- Hainan Shuangcheng Pharmaceuticals Co., Ltd. Elects Bai Jing as Non-Independent Director